$384.40
-0.72-0.19%
Last update: Oct 29, 4:00 PM
Bio-Rad Laboratories Inc (BIO) Stock Price, Quote, News & History
BIONYSE
Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family voting control could pose a hurdle.
You can purchase shares of Bio-Rad Laboratories (NYSE:BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Bio-Rad Laboratories has a consensus price target of $334.25.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $384.4 last updated October 29, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Bio-Rad Laboratories.
Bio-Rad Laboratories does not have any upcoming earnings scheduled.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and...
